Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01225198 · ClinicalTrials.gov registry record · Phase 2
Vitamin/Mineral Supplement for Children and Adults With Autism
A Phase 2 study, sponsored by Arizona State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 143
- Enrollment target
NCT01225198: Completed Phase 2 study, sponsored by Arizona State University.
NCT01225198 is a Phase 2 study that has completed, run by Arizona State University. The registered enrollment target is 143 participants, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01225198, a Phase 2 study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 143 participants
- Enrollment target
Study Summary
The investigators hypothesis is that a new, revised formulation of a vitamin/mineral supplement will result in: 1. improvement of nutritional status in some children/adults with autism, and 2. reduction of some of the symptoms of autism in some children
Primary Outcome
Level of Plasma Nitrotyrosine
Interventions
- DIETARY_SUPPLEMENT Multi-Vitamin/Mineral Supplement
- OTHER Liquid Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
What the finished NCT01225198 record still lists
NCT01225198 is an interventional study that assigns participants to a tested intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Multi-Vitamin/Mineral Supplement is the first listed.
NCT01225198 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01225198 about?
NCT01225198 is a clinical study titled "Vitamin/Mineral Supplement for Children and Adults With Autism". The investigators hypothesis is that a new, revised formulation of a vitamin/mineral supplement will result in: 1. improvement of nutritional status in some children/adults with autism, and 2. reduction of some of the symptoms of autism in some children
What is the current status of trial NCT01225198?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 143 participants. The study started on 2008-05. Estimated completion is 2009-02.
What interventions are being tested in trial NCT01225198?
The interventions under investigation include: Multi-Vitamin/Mineral Supplement (DIETARY_SUPPLEMENT), Liquid Placebo (OTHER).
Who is sponsoring clinical trial NCT01225198?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01225198's enrollment target sits among peer trials
143 507th of 2000 higher than 1,494 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia